STOCK TITAN
  1. Home
  2. Sec-filings
  3. CMPR
  4. [Form 4] CIMPRESS plc Insider Trading Activity

Cimpress (CMPR) Form 4: Director’s RSU vesting and tax share sale

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Cimpress plc (CMPR) director Sophie Gasperment reported equity transactions on 11/15/2025 involving the vesting of restricted share units (RSUs) and a share sale. Several RSU awards vested and converted into ordinary shares, including 351, 1,128, 494 and 638 ordinary shares, each at an exercise price of $0 as these are RSUs rather than options. Following these transactions, she continued to hold ordinary shares directly.

The filing also shows a disposition of 1,256 ordinary shares coded “F” at a price of $66.59, typically indicating shares withheld or sold to cover taxes associated with the vesting. The RSU awards referenced in Table II vest over four years, with 25% of the original RSU grant vesting on the initial vesting date and another 25% vesting each year thereafter.

Positive

  • None.

Negative

  • None.
Insider Gasperment Sophie
Role Director
Type Security Shares Price Value
Exercise Restricted Share Units (right to acquire) 351 $0.00 --
Exercise Restricted Share Units (right to acquire) 1,128 $0.00 --
Exercise Restricted Share Units (right to acquire) 494 $0.00 --
Exercise Restricted Share Units (right to acquire) 638 $0.00 --
Exercise Ordinary Shares 351 $0.00 --
Exercise Ordinary Shares 1,128 $0.00 --
Exercise Ordinary Shares 494 $0.00 --
Exercise Ordinary Shares 638 $0.00 --
Tax Withholding Ordinary Shares 1,256 $66.59 $84K
Holdings After Transaction: Restricted Share Units (right to acquire) — 0 shares (Direct); Ordinary Shares — 3,021 shares (Direct)
Footnotes (1)
  1. The shares acquired automatically vested pursuant to an award of restricted share units (RSUs), with each RSU representing Cimpress' commitment to issue one ordinary share. These RSUs vest over the following four-year period: 25% of the original number of RSUs granted vest on the Date Exercisable in Table II and 25% of such number of RSUs vest yearly thereafter.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gasperment Sophie
(Last) (First) (Middle)
CIMPRESS PLC, FIRST FLOOR BUILDING 3
FINNABAIR BUSINESS & TECHNOLOGY PARK
(Street)
DUNDALK, COUNTY LOUTH, IRELAND
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CIMPRESS plc [ CMPR ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
11/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares 11/15/2025 M 351 A $0(1) 3,021 D
Ordinary Shares 11/15/2025 M 1,128 A $0(1) 4,149 D
Ordinary Shares 11/15/2025 M 494 A $0(1) 4,643 D
Ordinary Shares 11/15/2025 M 638 A $0(1) 5,281 D
Ordinary Shares 11/15/2025 F 1,256 D $66.59 4,025 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Share Units (right to acquire) $0(1) 11/15/2025 M 351 11/15/2022(2) 11/15/2025 Ordinary Shares 351 $0 0 D
Restricted Share Units (right to acquire) $0(1) 11/15/2025 M 1,128 11/15/2023(2) 11/15/2026 Ordinary Shares 1,128 $0 1,127 D
Restricted Share Units (right to acquire) $0(1) 11/15/2025 M 494 11/15/2024(2) 11/15/2027 Ordinary Shares 494 $0 987 D
Restricted Share Units (right to acquire) $0(1) 11/15/2025 M 638 11/15/2025(2) 11/15/2028 Ordinary Shares 638 $0 1,913 D
Explanation of Responses:
1. The shares acquired automatically vested pursuant to an award of restricted share units (RSUs), with each RSU representing Cimpress' commitment to issue one ordinary share.
2. These RSUs vest over the following four-year period: 25% of the original number of RSUs granted vest on the Date Exercisable in Table II and 25% of such number of RSUs vest yearly thereafter.
Remarks:
/s/ Matthew F. Walsh, as attorney-in-fact for Sophie Gasperment 11/18/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider activity did Cimpress (CMPR) report in this Form 4?

The Form 4 reports that director Sophie Gasperment had several restricted share unit (RSU) awards vest into ordinary shares on 11/15/2025 and also reported a disposition of ordinary shares.

How many Cimpress (CMPR) shares vested for the director on 11/15/2025?

On 11/15/2025, RSU awards vested and converted into ordinary shares in amounts of 351, 1,128, 494, and 638 shares, each at an effective exercise price of $0 per share.

How many Cimpress (CMPR) shares were disposed of and at what price?

The director reported a disposition coded “F” of 1,256 ordinary shares at a price of $66.59 per share, which typically reflects shares withheld or sold to satisfy tax obligations upon vesting.

What are the terms of the Cimpress (CMPR) RSU vesting schedule?

The RSUs vest over a four-year period: 25% of the original number of RSUs vests on the initial vesting date shown in Table II, and an additional 25% vests each year thereafter until fully vested.

Does the Cimpress (CMPR) Form 4 show derivative securities remaining after the transactions?

Yes. After certain RSU tranches vested and converted into ordinary shares, the filing shows remaining restricted share units in Table II, with updated amounts of derivative securities beneficially owned following the reported transactions.

What role does the reporting person hold at Cimpress (CMPR)?

The reporting person, Sophie Gasperment, is identified as a Director of Cimpress plc in the filing.